Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of obesity. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://aronpult298618.blogtov.com/19603523/retaglutide-a-promising-glp-1-receptor-agonist